The CEASE-AF trial shows Hybrid ablation’s ~33% improvement in freedom from atrial arrhythmias* over 24 months for LSPAF**. Discover more about Hybrid AF™ Therapy at <a href="https://twitter.com/hashtag/AHA2024.?src=hashtag_click" target="_blank">#AHA2024.</a> Learn more here: <a href="https://t.co/Zs4xjdLb6U" target="_blank">https://t.co/Zs4xjdLb6U</a>
*Freedom from atrial arrhythmias (atrial fibrillation,… <a href="https://t.co/JWybCCHKUx" target="_blank">https://t.co/JWybCCHKUx</a>